Zafirlukast attenuates advanced glycation end-products (AGEs)-induced degradation of articular extracellular matrix (ECM)
- 1 March 2019
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 68, 68-73
Abstract
No abstract availableKeywords
Funding Information
- Huazhong University of Science and Technology (2017Y18)
This publication has 20 references indexed in Scilit:
- The role of leukotrienes in allergic diseasesAllergology International, 2015
- The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 studyAnnals of the Rheumatic Diseases, 2014
- A review on leukotrienes and their receptors with reference to asthmaJournal of Asthma, 2013
- Advanced glycation end products cause collagen II reduction by activating Janus kinase/signal transducer and activator of transcription 3 pathway in porcine chondrocytesRheumatology, 2011
- Cysteinyl Leukotrienes and Their Receptors: Molecular and Functional CharacteristicsPharmacology, 2010
- Enhanced fracture repair by leukotriene antagonism is characterized by increased chondrocyte proliferation and early bone formation: A novel role of the cysteinyl LT‐1 receptorJournal of Cellular Physiology, 2009
- Mechanisms of Disease: advanced glycation end-products and their receptor in inflammation and diabetes complicationsNature Clinical Practice Endocrinology & Metabolism, 2008
- Interaction of the Receptor for Advanced Glycation End Products (RAGE) with Transthyretin Triggers Nuclear Transcription Factor kB (NF-kB) ActivationLaboratory Investigation, 2000
- Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-jun N-terminal kinase, and nuclear factor κB: Differential regulation of collagenase 1 and collagenase 3Arthritis & Rheumatism, 2000
- The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB ActivationCell, 1997